Literature DB >> 3148151

Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin.

P J Fletcher1.   

Abstract

Two series of experiments examined whether 5-hydroxytryptamine (5-HT) antagonists induce feeding in rats. In the first series of experiments separate groups of rats were injected with various doses of methysergide, cyproheptadine, metergoline or ritanserin prior to a 2 h period of access to a wet mash diet which induced vigorous feeding under control conditions. None of the antagonists increased food intake in this paradigm. Rather, at certain doses, methysergide, cyproheptadine and ritanserin induced slight decreases in food intake. Since 5-HT may be involved in controlling satiety, it may be that a more appropriate test of the efficacy of these compounds involves administering them to maximally satiated rats. Consequently, the effects of these drugs were investigated in groups of rats which had fed to satiety immediately prior to drug treatment. In this paradigm methysergide, metergoline and ritanserin, but not cyproheptadine, induced definite increases in food intake. It is suggested that this effect occurs via a dissipation of satiety signals, and that these results further support the hypothesis that 5-HT is involved in controlling satiety. The possibility that these antagonists act on peripheral 5-HT systems is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148151     DOI: 10.1007/bf00177567

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats.

Authors:  B G Hoebel; F P Zemlan; M E Trulson; R G MacKenzie; R P DuCret; C Norelli
Journal:  Ann N Y Acad Sci       Date:  1978-06-12       Impact factor: 5.691

2.  Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine.

Authors:  C F Saller; E M Stricker
Journal:  Science       Date:  1976-04-23       Impact factor: 47.728

3.  Inhibition of drug-induced anorexia in rats by methysergide.

Authors:  A M Barrett; L McSharry
Journal:  J Pharm Pharmacol       Date:  1975-12       Impact factor: 3.765

Review 4.  Serotonin manipulations and the structure of feeding behaviour.

Authors:  J E Blundell
Journal:  Appetite       Date:  1986       Impact factor: 3.868

5.  The effect of cyproheptadine on hunger, calorie intake and body weight in man.

Authors:  T Silverstone; D Schuyler
Journal:  Psychopharmacologia       Date:  1975

6.  The anorectic action of peripheral 5-HT examined in the runway: evidence for an action on satiation.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Peripherally administered serotonin decreases food intake in rats.

Authors:  J D Pollock; N Rowland
Journal:  Pharmacol Biochem Behav       Date:  1981-08       Impact factor: 3.533

8.  Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine.

Authors:  L A Baez; R A Browning; M Cusatis
Journal:  Prog Neuropsychopharmacol       Date:  1980

9.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

10.  Effects of manipulations of peripheral serotonin on feeding and drinking in the rat.

Authors:  P J Fletcher; M J Burton
Journal:  Pharmacol Biochem Behav       Date:  1984-06       Impact factor: 3.533

View more
  12 in total

1.  Evidence for 5-HT2 receptor mediation in quipazine anorexia.

Authors:  R Shukla; D MacKenzie-Taylor; R H Rech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Estradiol increases the anorexia associated with increased 5-HT(2C) receptor activation in ovariectomized rats.

Authors:  Heidi M Rivera; Jessica Santollo; Larissa V Nikonova; Lisa A Eckel
Journal:  Physiol Behav       Date:  2011-08-25

3.  Inhibitory neurotransmitter serotonin and excitatory neurotransmitter dopamine both decrease food intake in Chinese perch (Siniperca chuatsi).

Authors:  Yu-Hui He; Ling Li; Xu-Fang Liang; Shan He; Luo Zhao; Yan-Peng Zhang
Journal:  Fish Physiol Biochem       Date:  2017-09-19       Impact factor: 2.794

4.  Selective reduction by serotonergic agents of hypertonic saline consumption in rats: evidence for possible 5-HT1C receptor mediation.

Authors:  J C Neill; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism.

Authors:  P J Fletcher; M Davies
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 6.  Olfactory-induced locomotion in lampreys.

Authors:  Philippe-Antoine Beauséjour; Barbara Zielinski; Réjean Dubuc
Journal:  Cell Tissue Res       Date:  2021-10-21       Impact factor: 5.249

7.  The effects of 5-HT on feeding behaviour in mianserin- or cyproheptadine-pretreated rats.

Authors:  J M Mancilla-Díaz; R E Escartín-Pérez; V E López-Alonso
Journal:  Eat Weight Disord       Date:  2003-12       Impact factor: 4.652

8.  Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.

Authors:  G A Kennett; K Pittaway; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 9.  Molecular signaling involved in regulating feeding and other motivated behaviors.

Authors:  Todd R Gruninger; Brigitte LeBoeuf; Yishi Liu; L Rene Garcia
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

10.  Dopamine D2/3 receptor antagonism reduces activity-based anorexia.

Authors:  S J Klenotich; E V Ho; M S McMurray; C H Server; S C Dulawa
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.